Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Adalimumab elicits a restricted anti-idiotypic antibody response in autoimmune patients resulting in functional neutralisation.
van Schouwenburg PA, van de Stadt LA, de Jong RN, van Buren EE, Kruithof S, de Groot E, Hart M, van Ham SM, Rispens T, Aarden L, Wolbink GJ, Wouters D. van Schouwenburg PA, et al. Among authors: van ham sm, van de stadt la, van buren ee, de jong rn, de groot e. Ann Rheum Dis. 2013 Jan;72(1):104-9. doi: 10.1136/annrheumdis-2012-201445. Epub 2012 Jul 3. Ann Rheum Dis. 2013. PMID: 22759910
The extent of the anti-citrullinated protein antibody repertoire is associated with arthritis development in patients with seropositive arthralgia.
van de Stadt LA, van der Horst AR, de Koning MH, Bos WH, Wolbink GJ, van de Stadt RJ, Pruijn GJ, Dijkmans BA, van Schaardenburg D, Hamann D. van de Stadt LA, et al. Among authors: de koning mh, van schaardenburg d, van de stadt rj, van der horst ar. Ann Rheum Dis. 2011 Jan;70(1):128-33. doi: 10.1136/ard.2010.132662. Epub 2010 Nov 9. Ann Rheum Dis. 2011. PMID: 21062853
Monoclonal anti-citrullinated protein antibodies selected on citrullinated fibrinogen have distinct targets with different cross-reactivity patterns.
van de Stadt LA, van Schouwenburg PA, Bryde S, Kruithof S, van Schaardenburg D, Hamann D, Wolbink G, Rispens T. van de Stadt LA, et al. Among authors: van schouwenburg pa, van schaardenburg d. Rheumatology (Oxford). 2013 Apr;52(4):631-5. doi: 10.1093/rheumatology/kes371. Epub 2012 Dec 22. Rheumatology (Oxford). 2013. PMID: 23264551
ACPA epitopes - what are we actually looking at?
van de Stadt LA, Rispens T. van de Stadt LA, et al. Nat Rev Rheumatol. 2019 Mar;15(3):130-132. doi: 10.1038/s41584-018-0157-7. Nat Rev Rheumatol. 2019. PMID: 30626908 No abstract available.
The type I IFN signature as a biomarker of preclinical rheumatoid arthritis.
Lübbers J, Brink M, van de Stadt LA, Vosslamber S, Wesseling JG, van Schaardenburg D, Rantapää-Dahlqvist S, Verweij CL. Lübbers J, et al. Among authors: van de stadt la, van schaardenburg d. Ann Rheum Dis. 2013 May;72(5):776-80. doi: 10.1136/annrheumdis-2012-202753. Epub 2013 Feb 23. Ann Rheum Dis. 2013. PMID: 23434571
Anti-citrullinated protein antibodies acquire a pro-inflammatory Fc glycosylation phenotype prior to the onset of rheumatoid arthritis.
Rombouts Y, Ewing E, van de Stadt LA, Selman MH, Trouw LA, Deelder AM, Huizinga TW, Wuhrer M, van Schaardenburg D, Toes RE, Scherer HU. Rombouts Y, et al. Among authors: van de stadt la, van schaardenburg d. Ann Rheum Dis. 2015 Jan;74(1):234-41. doi: 10.1136/annrheumdis-2013-203565. Epub 2013 Oct 8. Ann Rheum Dis. 2015. PMID: 24106048
44 results